Matthew Pauls insider trades
Open-market stock purchases and sales by Matthew Pauls, Director at Pelthos Therapeutics Inc, from SEC Form 4 filings since Apr 1, 2013.
Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +181%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $2.6K |
| Jul 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $18K |
| May 18, 2026 | SLNO Soleno Therapeutics Inc | Sold (not open market) | — |
| May 18, 2026 | SLNO Soleno Therapeutics Inc | Sold (not open market) | $41.7K |
| Apr 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $8.5K |
| Apr 2, 2026 | PTHS Pelthos Therapeutics Inc | Sold | $7.9K |
| Dec 16, 2025 | SVRA Savara Inc | Sold (not open market) | — |
| Dec 14, 2025 | SVRA Savara Inc | Sold (not open market) | $1.4M |
| Dec 10, 2025 | PTHS Pelthos Therapeutics Inc | Sold (not open market) | — |
| Dec 10, 2025 | SVRA Savara Inc | Sold (not open market) | — |
| Oct 2, 2025 | PTHS Pelthos Therapeutics Inc | Bought (not open market) | — |
Companies traded
- PTHS Pelthos Therapeutics Inc: 4 sales, last Jul 2, 2026
- SLNO Soleno Therapeutics Inc: 1 sale, last May 18, 2026
- SVRA Savara Inc: 11 buys, 2 sales, last Dec 16, 2025
- ZCOR Zyla Life Sciences: other filings, last May 20, 2020
- SBBP Strongbridge Biopharma plc: other filings, last Feb 26, 2018
- MSTX Mast Therapeutics, Inc: other filings, last Jan 23, 2017
- INSM Insmed Inc: other filings, last Jun 2, 2014